184969-91-3

Upstream product

• 184969-90-2 [3-[2-(3,5-bis-trifluoromethyl-benzyloxymethyl)-[1,3]dithiolan-2-yl]-3-(3,4-dichloro-phenyl)-propoxy]-tert-butyl-dimethyl-silane 
• 184969-89-9 {2-[3-(tert-butyl-dimethyl-silanyloxy)-1-(3,4-dichloro-phenyl)-propyl]-[1,3]dithiolan-2-yl}-methanol 
• 184969-85-5 2-[1-(3,4-dichloro-phenyl)-2-methoxycarbonyl-ethyl]-[1,3]dithiolane-2-carboxylic acid ethyl ester 
• 184969-87-7 3-(3,4-dichloro-phenyl)-3-(2-hydroxymethyl-[1,3]dithiolan-2-yl)-propan-1-ol 
• 82475-75-0 methyl 3-(3,4-dichlorophenyl)-2-propenoate 
• 315718-17-3 3-[2-(3,5-bis-trifluoromethyl-benzyloxymethyl)-[1,3]dithiolan-2-yl]-3-(3,4-dichloro-phenyl)-propan-1-ol 

Downstream Products

• 184970-05-6 1-[[3,5-bis(trifluoromethyl)phenyl]methoxy]-3-(3,4-dichlorophenyl)-5-formyl-2(Z)-pentanone O-methyl-oxime 
• 184969-93-5 1-(3,5-bis-trifluoromethyl-benzyloxy)-3-(3,4-dichloro-phenyl)-5-hydroxy-pentan-2-one O-methyl-oxime 

Relevant academic research and scientific papers

Synthesis and NK1/NK2 receptor activity of substituted-4(Z)-(methoxyimino)pentyl-1-piperazines

A series of 5-[(3,5-bis(trifluoromethyl)phenyl)methoxy]-3-(3,4-dichlorophenyl)-4(Z)-(meth oxyimino)pentyl-1-piperazines was prepared and their affinity for the NK1 and NK2 receptors investigated. Compounds 7f, 10o, 10r, and 10s were

SUBSTITUTED OXIMES, HYDRAZONES AND OLEFINS AS NEUROKININ ANTAGONISTS

Compound represented by the structural formula STR1 or a pharmaceutically acceptable salt thereof, wherein: a is 0, 1, 2 or3; b, d and e are independently 0, 1 or 2;R is H, C 1-6 alkyl,--OH or C 2-C 6 hydroxyalkyl;A is an optionally su

SUBSTITUTED OXIMES, HYDRAZONES AND OLEFINS AS NEUROKININ ANTAGONISTS

Compound represented by the structural formula STR1 or a pharmaceutically acceptable salt thereof, wherein: a is 0, 1, 2 or 3;b, d and e are independently 0, 1 or 2;R is H, C 1-6 alkyl,--OH or C 2-C 6 hydroxyalkyl; A is an optionally s